Spectrum Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
66 Contracts & Agreements
- Description of Equity Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 18, 2022)
- Description of Equity Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 31, 2021)
- Description of Equity Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 2, 2020)
- Second Amendment to Rights Agreement, dated March 27, 2018, by and between Spectrum Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent (Filed With SEC on March 29, 2018)
- Sublicense Agreement, dated December 21, 2007, by and among Cell Therapeutics, Inc., Biogen Idec Inc., Corixa Corporation, Coulter Pharmaceutical, Inc., The Regents of the... (Filed With SEC on March 7, 2018)
- First Amendment to Rights Agreement, by and between Spectrum Pharmaceuticals, Inc. and Computershare Trust Company, N.A., as Rights Agent, dated October 13, 2017 (Filed With SEC on October 13, 2017)
- CO-PROMOTION AGREEMENT (Filed With SEC on March 14, 2016)
- CONTINGENT VALUE RIGHTS AGREEMENT (Filed With SEC on July 19, 2013)
- SUBLICENSE AGREEMENT (Filed With SEC on November 9, 2012)
- SUBLICENSE AGREEMENT (Filed With SEC on November 9, 2012)
- LICENSE-BACK AGREEMENT (Filed With SEC on November 9, 2012)
- CONTINGENT VALUE RIGHTS AGREEMENT (Filed With SEC on April 5, 2012)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 4, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 4, 2011)
- Exhibit Number (Filed With SEC on September 23, 2009)
- Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on September 23, 2009)
- Financial Statements (Filed With SEC on August 13, 2009)
- Financial Statements (Filed With SEC on August 13, 2009)
- Financial Statements (Filed With SEC on August 13, 2009)
- Financial Statements (Filed With SEC on August 13, 2009)
- Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20thFloor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on July 2, 2009)
- Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20thFloor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on June 18, 2009)
- Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on May 28, 2009)
- Exhibit Number (Filed With SEC on May 7, 2009)
- Exhibit No (Filed With SEC on May 4, 2007)
- Exhibit No (Filed With SEC on May 4, 2007)
- SECOND AMENDMENT TO LICENCE AGREEMENT (Filed With SEC on March 2, 2007)
- AMENDMENTNO. 5 TOTHE RIGHTSAGREEMENT DATEDAS OF DECEMBER 13, 2000 BYAND BETWEEN SPECTRUMPHARMACEUTICALS, INC. AND U.S.STOCK TRANSFER CORPORATION (Filed With SEC on November 3, 2006)
- FOURTH AMENDMENT TO THE RIGHTS AGREEMENT (Filed With SEC on July 12, 2006)
- Description of Document (Filed With SEC on September 22, 2005)
- Description of Document (Filed With SEC on September 15, 2005)
- Description of Document (Filed With SEC on September 15, 2005)
- Description of Document (Filed With SEC on September 15, 2005)
- Description of Document (Filed With SEC on May 20, 2005)
- Description of Document (Filed With SEC on April 19, 2005)
- Description of Document (Filed With SEC on February 25, 2005)
- Description of Document (Filed With SEC on February 3, 2005)
- Description of Document (Filed With SEC on December 17, 2004)
- Description of Document (Filed With SEC on November 8, 2004)
- Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked [* * *] and has been filed separately with the Securities and Exchange Commission pursuant... (Filed With SEC on March 14, 2007)
